Specialty Pharmacy

Effective therapies in liver transplant patients reduces HCV recurrence.

App developers need to ensure mHealth apps are HIPAA-compliant by design.

CMS aims to provide choice and competition for consumers and improve the consumer experience.

Patients treated with HIV therapy less likely to get infected with HBV.

In addition to facing the risk of fatal overdose, kidney disease, and pneumonia, heroin users also have a greater likelihood of acquiring HIV.

Long-term care pharmacies' current prescription drug reimbursement model may not be sustainable, a new analysis suggests.

Concerns raised from combining medical marijuana dispensaries with recreational dispensaries.

Latest news in cancer drug development.

Patients treated with HIV therapy less likely to get infected with HBV.

Ixazomib is an oral proteasome inhibitor used in combination with lenalidomide and dexamethasone.

Patients on Medicaid more likely to have HCV infection and much more likely to be denied coverage.

Top stories of the week on Specialty Pharmacy Times.

Study suggests increasing oxidative stress through with pro-oxidants may prevent metastasis.

Quality of life after surgical treatment is an important part of recovery.

A majority of life sciences companies are planning on acquisitions and are targeting companies with a personalized medicine focus.

Legislators evaluate negotiation and pricing practices in the pharmacy industry.

Women with type 2 diabetes have greater difficulty with exercise than those without the condition.

Specialty drugs for chronic, rare, and genetic diseases are forecast to drive a $298 billion increase in brand spending.

Treatment helps reduce infection risk from low white blood cell count in cancer patients receiving chemotherapy.

Molecular mechanisms behind acute myeloid leukemia may offer a new target for drug development.

Biologic pathway associated with neural stem cells can affect the growth of some cancers.

Vitamin D deficiency may impact immune recovery in patients with HIV.

The action by NICE highlights discussion on both sides of the Atlantic about the cost of PCSK9 inhibitors, which lower LDL cholesterol.

Being a pharmacist in today's world means more than just filling prescriptions. Building and maintaining patient relationships should be the No. 1 priority for practicing pharmacists.

Novel drug shows promise in chronic lymphocytic leukemia and non-Hodgkin lymphoma refractory or resistant to current chemotherapies.

Atheer Kaddis, PharmD, senior vice president of Business Development and Sales at Diplomat, discusses retail network services.

FDA requests a more thorough review of rociletinib from ongoing trial.

B cell depletion therapy decreases new disease activity in people with relapsing-remitting MS.